IVGAX
Price
$22.59
Change
-$0.40 (-1.74%)
Updated
Feb 21 closing price
Net Assets
157.69M
RMFEX
Price
$57.60
Change
-$0.62 (-1.06%)
Updated
Feb 21 closing price
Net Assets
105.48B
Ad is loading...

IVGAX vs RMFEX

Header iconIVGAX vs RMFEX Comparison
Open Charts IVGAX vs RMFEXBanner chart's image
VY® Invesco Growth and Income A
Price$22.59
Change-$0.40 (-1.74%)
VolumeN/A
Net Assets157.69M
American Funds American Mutual R4
Price$57.60
Change-$0.62 (-1.06%)
VolumeN/A
Net Assets105.48B
IVGAX vs RMFEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IVGAX vs. RMFEX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVGAX is a Hold and RMFEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 105B vs. IVGAX (158M). RMFEX pays higher dividends than IVGAX: RMFEX (1.95) vs IVGAX (1.23). IVGAX was incepted earlier than RMFEX: IVGAX (21 years) vs RMFEX (23 years). IVGAX has a lower initial minimum investment than RMFEX: IVGAX (0) vs RMFEX (250). RMFEX annual gain was more profitable for investors over the last year : 11.37 vs. IVGAX (2.77). RMFEX return over 5 years is better than : 43.97 vs. IVGAX (7.43).
IVGAXRMFEXIVGAX / RMFEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years23 years-
Gain YTD3.7674.88077%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets158M105B0%
Annual Yield % from dividends1.231.9563%
Returns for 1 year2.7711.3724%
Returns for 3 years-10.2120.81-49%
Returns for 5 years7.4343.9717%
Returns for 10 years-16.6071.03-23%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EWBC93.89-3.23
-3.33%
East West Bancorp
SIGA5.91-0.22
-3.51%
SIGA Technologies
INTA66.11-3.25
-4.69%
Intapp
BMEA3.46-0.19
-5.21%
Biomea Fusion
CNSP3.23-0.52
-13.87%
CNS Pharmaceuticals Inc.